The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy by Feng Zhang, Siyuan Wang, Chao Yu, Wenying Jin, Dan He, Xiaoxiao Hu, Shu Wang, Tiangang Zhu

Subjects: Get full text

Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first‐line options for HER2‐positive relapsed or metastatic breast cancer by Xiuwen Guan, Fei Ma, Binghe Xu

Subjects: Get full text

Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo by Hao Liu, Sanbao Ruan, Margaret E. Larsen, Congcong Tan, Bolin Liu, Hui Lyu

Subjects: Get full text

A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations by Jing Ma, Xuelu Li, Qianran Zhang, Ning Li, Siwen Sun, Shanshan Zhao, Zuowei Zhao, Man Li

Subjects: Get full text

Late cardiotoxicity related to HER2-targeted cancer therapy by Isabelle Senechal, Maria Sol Andres, Jieli Tong, Ylenia Perone, Sivatharshini Ramalingam, Muhummad Sohaib Nazir, Stuart D Rosen, Nicholas Turner, Alistair Ring, Alexander R Lyon

Subjects: Get full text

Risk and prognostic factors of breast cancer with liver metastases by Lei Ji, Lei Cheng, Xiuzhi Zhu, Yu Gao, Lei Fan, Zhonghua Wang

Subjects: Get full text

Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma by Martina Napolitano, Lucia Trudu, Enrica Martinelli, Chiara Santini, Massimo Dominici, Federica Bertolini

Subjects: Get full text

Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells by Shen Y, Zhang J, Hao W, Wang T, Liu J, Xie Y, Xu S, Liu H

Subjects: Get full text

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015) by Benjamin Daniels, Belinda E. Kiely, Monica Tang, Hanna Tervonen, Sallie-Anne Pearson

Subjects: Get full text

Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 1... by Claire Phillips, Mark B. Pinkham, Alisha Moore, Joseph Sia, Rosalind L. Jeffree, Mustafa Khasraw, Anthony Kam, Mathias Bressel, Annette Haworth

Subjects: Get full text

Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies by Cheng Zhang, Zuhua Chen, Xiaoyi Chong, Yang Chen, Zhenghang Wang, Ruoying Yu, Tingting Sun, Xiaoxi Chen, Yang Shao, Xiaotian Zhang, Jing Gao, Lin Shen

Subjects: Get full text

Clinicopathological characteristics, treatment patterns and outcomes in patients with HER2-positive breast cancer based on hormone receptor status: a retrospective study by Ran Ran, Shidi Zhao, Yan Zhou, Xinyue Hang, Hui Wang, Yuan Fan, Yusi Zhang, Yifan Qiao, Jin Yang, Danfeng Dong

Subjects: Get full text

HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies by Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby

Subjects: Get full text

Case report: Unraveling a unique case of male occult breast cancer with axillary intricacies and a comprehensive literature dive by Xintong Xie, Xiangyi Kong, Xiangyi Kong, Hongnan Jiang, Jidong Gao, Jidong Gao

Subjects: Get full text

HER2-Low Breast Cancer: Current Landscape and Future Prospects by Shirman Y, Lubovsky S, Shai A

Subjects: Get full text

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast c... by Nalee Kim, Ji-Yeon Kim, Won Park, Won Kyung Cho, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu, Yeon Hee Park, Haeyoung Kim

Subjects: Get full text

Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction by Huiyu Xiao, Xiaojie Wang, Shuang Li, Ying Liu, Yijie Cui, Xiaoqin Deng

Subjects: Get full text

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives by Weiling Li, Xiaoling Zhang, Yunyi Du, Ying Zhang, Jing Lu, Wenqing Hu, Jun Zhao

Subjects: “…HER2-targeted therapy…”
Get full text

iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data by Sanghoon Lee, Min Sun, Yiheng Hu, Yue Wang, Md N. Islam, David Goerlitz, Peter C. Lucas, Adrian V. Lee, Sandra M. Swain, Gong Tang, Xiao-Song Wang

Subjects: Get full text

Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance by Claudiu Morgovan, Carmen Maximiliana Dobrea, Anca Butuca, Anca Maria Arseniu, Adina Frum, Luca Liviu Rus, Adriana Aurelia Chis, Anca Maria Juncan, Felicia Gabriela Gligor, Cecilia Georgescu, Steliana Ghibu, Andreea Loredana Vonica-Tincu

Subjects: Get full text